Selective Serotonin Reuptake Inhibitor-Induced Disturbances of Haemostasis: Mechanisms and Therapeutic Implications

By Berk M.  

CNS Drugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 441-446

Adis International

Access to resources Recommend Favorite

Protease Inhibitor-Induced Diabetic Complications: Incidence, Management and Prevention

By Lien Lillian F.   Feinglos Mark N.  

Drug Safety, Vol. 28, Iss. 3, 2005-01 ,pp. : 209-226

Adis International

Access to resources Recommend Favorite

Potentiation of opioid-induced conditioned place preference by the selective serotonin reuptake inhibitor fluoxetine

By Subhan F.   Pache D.M.   Sewell R.D.E.  

European Journal of Pharmacology, Vol. 390, Iss. 1, 2000-02 ,pp. : 137-143

Elsevier

Access to resources Recommend Favorite

Catalepsy induced by the 5-HT 1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram

By Eltayb A.   Svensson T.H.   Ahlenius S.  

European Journal of Pharmacology, Vol. 411, Iss. 3, 2001-01 ,pp. : 275-277

Elsevier

Access to resources Recommend Favorite

The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson’s disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram

By Kuan Wei-Li   Zhao Jing-Wei   Barker Roger  

Psychopharmacology, Vol. 197, Iss. 2, 2008-04 ,pp. : 279-293

Springer Publishing Company

Access to resources Recommend Favorite